Launch of the UK Synthetic Biology Strategic Plan 2016 - ‘Biodesign for the Bioeconomy’ on 24th February 2016
February 24 2016
Venue: Imperial College
Organised by: SBLC
Minister for Life Sciences George Freeman MP visited SynbiCITE at Imperial College London, the UK innovation and knowledge centre for synthetic biology, on 24th February 2016 to announce the release of the UK Synthetic Biology Strategic Plan 2016 — Biodesign for the Bioeconomy.
This strategic plan, published by the Synthetic Biology Leadership Council (SBLC), aims to accelerate the commercialisation of synthetic biology products and services with clear public benefit, building upon the strength of the UK research base. It focuses on five key areas of strategic importance:
- Accelerating industrialisation and commercialisation
- Maximising the capability of the innovation pipeline
- Building an expert workforce
- Developing a supportive business environment, and
- Building value from national and international partnerships.
It builds on the recommendations made in the Synthetic Biology Roadmap for the UK, which was first published by Innovate UK in 2012. The roadmap led directly to major funding and policy activities, including the establishment of new synthetic biology research centres, the Innovation and Knowledge Centre at SynbiCITE, DNA synthesis facilities, training centres and a seed fund for innovative companies. In addition, the Synthetic Biology Leadership Council (SBLC) was founded to manage the continued growth of this field.
During 2015, the Synthetic Biology Leadership Council (SBLC) consulted a broad cross-section of businesses and the research community to develop this new strategic plan, building upon the successes of the 2012 roadmap.
The full press release for this event is available here.
The UK Synthetic Biology Strategic Plan 2016 — Biodesign for the Bioeconomy document can be accessed here.